In fact, some existing studies have confirmed that the combination of metabolic characteristics of cholesterol and estrogen exerts synergistic effects in EGFR-TKI resistance in lung cancer51 and prognosis of breast cancer52. This evidence concerns the gene EGFR and medical procedure.